OnKure enters ATM offering agreement with Leerink Partners; up to 3% fee

OnKure Therapeutics, Inc.

Sales agreement with Leerink Partners for at-the-market offering of Class A common stock.
Compensation set at 3.0% of gross proceeds from sales of Placement Shares.
No minimum offering amount; company may suspend sales at any time.
Sales commence only after SEC registration statement becomes effective.
Agreement contains customary representations, warranties, and termination provisions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.